WHO Pharmaceuticals Newsletter 2003, No. 04
(2003; 13 pages) View the PDF document
Table of Contents
Open this folder and view contentsREGULATORY MATTERS
Close this folderSAFETY OF MEDICINES
View the documentATYPICAL ANTI-PSYCHOTICS - Reports of hypertension
View the documentBOTULINUM A - Patients misled over safety
View the documentCHELIDONIUM MAJUS - Statement to advise use under supervision
View the documentCYCLO-OXYGENASE (COX)-2 INHIBITORS - Reports of hepatotoxicity
View the documentETONOGESTREL - Vaginal bleeding with sub-dermal implant
View the documentFLUTICASONE - ADR update
View the documentGATIFLOXACIN - Reports of abnormal glucose metabolism
View the documentHORMONE REPLACEMENT THERAPY (HRT) - ‘Million Women Study’ confirms breast cancer association
View the documentMEDROXY-PROGESTERONE - Reports of contraception failure with depot preparations
View the documentMEFLOQUINE - Patient guide warns of psychiatric adverse events
View the documentMETHOTREXATE - New solutions to prevent fatalities/adverse events
View the documentMINOCYCLINE - Hepatic reactions
View the documentPIPERACILLIN - Serum methotrexate monitoring advised during concomitant therapy
View the documentRIFAMPICIN & PYRAZINAMIDE - Warning against use in latent tuberculosis
View the documentSELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs): Reports of hyponatraemia
View the documentSIBUTRAMINE - Serotonin syndrome
View the documentTICLOPIDINE - No decrease in ADR reports
View the documentVIGA/VIGA FOR WOMEN - Presence of sildenafil
View the documentWARFARIN & MICONAZOLE - Reminder about interaction
Open this folder and view contentsDRUGS IN THE NEWS
 

WARFARIN & MICONAZOLE - Reminder about interaction

New Zealand. In a Prescriber Update article prescribers and pharmacists in New Zealand have been reminded of the potentially serious interaction between miconazole oral gel (Daktarin oral gel) and warfarin leading to clinically significant elevations in INR. Six cases of an interaction between oral miconazole and warfarin resulting in INR increases have been reported in New Zealand. In four of these cases patients presented with haemarthrosis, haematuria, haemoptysis or epistaxis. INR values ranged from 7.5 to 18 and were > 10 in all patients with bleeding symptoms. The article also highlights reports of the interaction in Australia. There has also been one report of an interaction between topical miconazole cream and warfarin in Australia.

Reference:

Medsafe Editorial Team. Miconazole - warfarin interaction reminder. Prescriber Update: Therapeutics Section 24: 12, Jun 2003.

 

to previous section to next section
 

Last updated: May 3, 2013